Under a new cooperative agreement, DKSH will partner strategically with Polpharma, a frontrunner in Poland’s pharmaceutical market and a leading drug manufacturer in central and eastern Europe specializing in innovative drugs and solutions.

The partnership focuses on diversifying the supply of healthcare products, including those related to cardiovascular, digestive, nervous, respiratory, antibiotic, dermatological, and ophthalmic fields, in Vietnam.

Mr. Bernardo Reiner, Head of Business-to-Business Relations at Polpharma and CEO of Farmaprojects, expressed his confidence in the arrangement. “We believe that DKSH’s robust capabilities and deep understanding will not only help Polpharma realize business growth but also bring us closer to contributing to the development of the industry in potential markets like Vietnam,” he said.

“With DKSH, we will continue to contribute to bringing a healthy and long-lasting life to the people of Vietnam.”

This cooperation with Polpharma marks one of eight strategic partnerships DKSH’s Healthcare division has initiated during 2023 in Vietnam. It also solidifies its role as a reliable partner in providing strategic healthcare solutions, contributing to its journey of bringing good health to everyone.

“As a strategic healthcare solutions provider in Asia and globally, we are committed to consistently delivering high-quality services and a profound understanding of local markets, helping Polpharma achieve anticipated success in Vietnam,” said Mr. Phillip Wray, General Director of DKSH Pharma Vietnam.

“This strategic partnership also signifies DKSH’s commitment to enhancing quality of life, making it easier for millions of people in Vietnam to access high-quality European healthcare products from Polpharma.”